Altered brain activation pattern associated with drug-induced attenuation of enhanced depression-like behavior in rats bred for high anxiety

被引:73
作者
Muigg, Patrik
Hoelzl, Ulrike
Palfrader, Klara
Neumann, Inga
Wigger, Alexandra
Landgraf, Rainer
Singewald, Nicolas
机构
[1] Univ Innsbruck, Dept Pharmacol & Toxicol, A-6020 Innsbruck, Austria
[2] Univ Regensburg, Dept Zool, D-8400 Regensburg, Germany
基金
奥地利科学基金会;
关键词
antidepressant; c-Fos mapping; forced swim; HAB; HPA axis; paroxetine; stress coping;
D O I
10.1016/j.biopsych.2006.08.035
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: The enhanced depression-like behavior in the forced swim test displayed by rats selectively bred for high anxiety-related behavior (HAB) as compared with their low anxiety counterparts (LAB) is abolished by chronic paroxetine treatment. The aim of the present study was to identify neuronal substrates underlying this treatment response in HABS. Methods: The HAB rats received paroxetine (10 mg/kg/day) for 24 days via drinking water, and drug-induced modulation of neuronal activation patterns in response to forced swimming was mapped with the expression of the immediate early gene c-Fos as marker. Results: Chronic paroxetine treatment reduced the immobility scores during forced swimming, confirming the previously observed antidepressant-like effect in these animals, and attenuated the forced swim-induced c-Fos response in a restricted set (11 of 70) of brain areas. These included limbic areas such as the prelimbic cortex, parts of the amygdala, the bed nucleus of the stria terminalis, dorsal hippocampus, dorsal lateral septum as well as hypothalamic and hindbrain areas (dorsolateral periaqueductal gray [PAG], locus coeruleus). Untreated LAB rats, which displayed low depression-like behavior comparable to that of treated HABs, also showed low swim stress-induced c-Fos response in most of these same areas, further supporting an association of attenuated neuronal excitability in the identified areas with attenuated depression-like behavior. Conclusions: These findings indicate that modulation of neuronal activation in a restricted set of defined, mainly limbic as well as selected hypothalamic and hindbrain areas by paroxetine treatment is associated with the reduction of enhanced depression-like behavior in a psychopathological animal model.
引用
收藏
页码:782 / 796
页数:15
相关论文
共 127 条
  • [1] Strategies for productring faster acting antidepressants
    Adell, A
    Castro, E
    Celeda, P
    Bortolozzi, A
    Pazos, A
    Artigas, F
    [J]. DRUG DISCOVERY TODAY, 2005, 10 (08) : 578 - 585
  • [2] Alfonso J, 2005, REV NEUROSCIENCE, V16, P43
  • [3] Anand A, 2003, ANN NY ACAD SCI, V985, P370
  • [4] DO ANTIDEPRESSANTS STABILIZE MOOD THROUGH ACTIONS ON THE HYPOTHALAMIC-PITUITARY-ADRENOCORTICAL SYSTEM
    BARDEN, N
    REUL, JMHM
    HOLSBOER, F
    [J]. TRENDS IN NEUROSCIENCES, 1995, 18 (01) : 6 - 11
  • [5] CHRONIC DESIPRAMINE ALTERS STRESS-INDUCED BEHAVIORS AND REGIONAL EXPRESSION OF THE IMMEDIATE-EARLY GENE, C-FOS
    BECK, CHM
    FIBIGER, HC
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1995, 51 (2-3) : 331 - 338
  • [6] Swim-stress but not opioid withdrawal increases expression of c-fos immunoreactivity in rat periaqueductal gray neurons which project to the rostral ventromedial medulla
    Bellchambers, CE
    Chieng, B
    Keay, KA
    Christie, MJ
    [J]. NEUROSCIENCE, 1998, 83 (02) : 517 - 524
  • [7] Bernard JF, 1998, J COMP NEUROL, V401, P429
  • [8] Plasma catecholamine levels after fluoxetine treatment in depressive patients
    Blardi, P
    de Lalla, A
    Auteri, A
    Iapichino, S
    Dell'Erba, A
    Castrogiovanni, P
    [J]. NEUROPSYCHOBIOLOGY, 2005, 51 (02) : 72 - 76
  • [9] Enhanced nucleus accumbens dopamine and plasma corticosterone stress responses in adult rats with neonatal excitotoxic lesions to the medial prefrontal cortex
    Brake, WG
    Flores, G
    Francis, D
    Meaney, MJ
    Srivastava, LK
    Gratton, A
    [J]. NEUROSCIENCE, 2000, 96 (04) : 687 - 695
  • [10] Bremner JD, 1996, SYNAPSE, V23, P39, DOI 10.1002/(SICI)1098-2396(199605)23:1<39::AID-SYN5>3.0.CO